MorphoSys v. Janssen: Harder to Corner the Market on Antibody Patents  IPWatchdog.com

In MorphoSys AG v. Janssen Biotech, Inc., a district court invalidated broad antibody patents for not being sufficiently enabled, as well as coming near to …